Gemcitabine for Injection Anti-tumor Medicine

The main ingredient of this product is gemcitabine hydrochloride.

The excipients are mannitol and sodium acetate.

This product is a white loose block.

Injection of gemcitabine hydrochloride is indicated for the treatment of locally advanced or metastatic non-small cell lung cancer-- Locally advanced or metastatic pancreatic cancer-- Gemcitabine combined with paclitaxel is suitable for the treatment of recurrent, unresectable, locally recurrent or metastatic breast cancer after adjuvant/neoadjuvant chemotherapy. Unless clinically contraindicated, anthracycline antibiotics should have been used in previous chemotherapy.

50mg.

Please use under the guidance of a physician.

Gemcitabine may cause bone marrow suppression, leading to leukopenia, thrombocytopenia, and anemia after application.

Patients must monitor platelet, white blood cell, and granulocyte counts before each treatment with gemcitabine. When it is confirmed that there is drug-induced bone marrow suppression, chemotherapy should be suspended or the treatment plan should be modified (see [Dosage and Administration]). However, bone marrow suppression has a short duration and usually does not require a dose reduction, with few cases of treatment discontinuation.

The use of gemcitabine in patients who have already developed liver metastases or have a history of hepatitis, alcoholism, or cirrhosis may lead to worsening of potential liver dysfunction.

If gemcitabine is administered continuously with radiation therapy, the interval between gemcitabine chemotherapy and radiation therapy should be at least 4 weeks due to the possibility of severe radiation sensitization. If the patient's condition allows, the interval time can be shortened.

Pulmonary symptoms associated with gemcitabine treatment, sometimes even severe pulmonary symptoms such as pulmonary edema, interstitial pneumonia, or adult respiratory distress syndrome (ARDS), have been reported. The causes of these symptoms are still unclear. Once it occurs, consideration should be given to discontinuing gemcitabine. Early adoption of supportive treatment measures may help alleviate the condition.

Please proceed with the above and other situations under the guidance of a physician.

Sealed and stored in a dry place.

Hot Tags: gemcitabine for injection anti-tumor medicine, China gemcitabine for injection anti-tumor medicine manufacturers, suppliers, Lurasidone Hydrochloride Tablets, fat soluble vitamin, , Sodium Bicarbonate Infusion Electrolyte, Propofol Injection General Anesthetics, Enoxaparin Sodium Injection Prevent Thrombosis